Breast Cancer
News and reporting on breast cancer.
Lantern to Test AI-Developed Drug in Triple-Negative Breast Cancer Trial
The firm will test LP-184 as a monotherapy and in combination with a PARP inhibitor in patients who have DNA damage repair gene mutations.
Marengo Begins Phase Ib/II Trial of Invikafusp Alfa, Trodelvy in Certain Breast Cancers
The study will include two cohorts of breast cancer patients: triple-negative breast cancer and HR-positive, HER2-negative breast cancer.
AstraZeneca to Discuss Neoadjuvant Enhertu Regimen With Regulators Following Early Data Readout
Patients on Enhertu followed by a chemotherapy and dual anti-HER2 regimen fared better than those on standard therapy.
Liquid Biopsy Firm QCDx Closes $7M Financing Round
The proceeds will be used to launch a new diagnostic instrument, a breast cancer monitoring assay, and proprietary multiplex immunofluorescence reagent kits.
The subcutaneous Perjeta-Herceptin formulation, Phesgo, was a top driver of sales growth in the first quarter of 2025.
Mar 31, 2025
Mar 28, 2025